New frontiers in lung transplantation : a bioengineering perspective
(2024) In ERS Monograph 2024. p.277-285- Abstract
LTx remains the definitive treatment for end-stage lung disease, but the increasing demand for donor lungs outpaces the available supply. This chapter explores innovative approaches to expand the pool of viable donor lungs and reduce waiting times, which is crucial to lowering mortality rates among patients on transplant lists. Xenotransplantation, which has made its greatest strides using porcine grafts, presents a promising solution. Additionally, the development of artificial lungs offers another avenue to address the shortage. Artificial lung devices, ranging from extracorporeal to implantable systems, aim to provide temporary or permanent respiratory support, potentially reducing the reliance on human donors. This chapter also... (More)
LTx remains the definitive treatment for end-stage lung disease, but the increasing demand for donor lungs outpaces the available supply. This chapter explores innovative approaches to expand the pool of viable donor lungs and reduce waiting times, which is crucial to lowering mortality rates among patients on transplant lists. Xenotransplantation, which has made its greatest strides using porcine grafts, presents a promising solution. Additionally, the development of artificial lungs offers another avenue to address the shortage. Artificial lung devices, ranging from extracorporeal to implantable systems, aim to provide temporary or permanent respiratory support, potentially reducing the reliance on human donors. This chapter also discusses the role of gene and cell therapies in enhancing the function and survival of transplanted lungs. Ex vivo lung perfusion platforms are highlighted for their utility in delivering these therapies, optimising graft condition before transplantation. The integration of these bioengineering innovations could significantly impact the future of LTx, offering new lifelines to patients in need.
(Less)
- author
- Lindstedt, Sandra LU ; Perch, Michael ; Meloni, Federica and Niroomand, Anna LU
- organization
-
- Clinical and experimental lung transplantation (research group)
- LUCC: Lund University Cancer Centre
- WCMM-Wallenberg Centre for Molecular Medicine
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- NPWT technology (research group)
- DCD transplantation of lungs (research group)
- Thoracic Surgery
- publishing date
- 2024
- type
- Chapter in Book/Report/Conference proceeding
- publication status
- published
- subject
- host publication
- Lung Transplantation
- series title
- ERS Monograph
- editor
- Perch, M ; Meloni, F and Vos, R
- volume
- 2024
- pages
- 277 - 285
- publisher
- European Respiratory Society
- external identifiers
-
- scopus:85217878016
- ISSN
- 2312-508X
- DOI
- 10.1183/2312508X.10004924
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © ERS 2024.
- id
- 31d25e87-0ee9-4862-aa6b-4d2a5546968c
- date added to LUP
- 2025-04-02 09:33:02
- date last changed
- 2025-04-04 14:03:58
@inbook{31d25e87-0ee9-4862-aa6b-4d2a5546968c, abstract = {{<p>LTx remains the definitive treatment for end-stage lung disease, but the increasing demand for donor lungs outpaces the available supply. This chapter explores innovative approaches to expand the pool of viable donor lungs and reduce waiting times, which is crucial to lowering mortality rates among patients on transplant lists. Xenotransplantation, which has made its greatest strides using porcine grafts, presents a promising solution. Additionally, the development of artificial lungs offers another avenue to address the shortage. Artificial lung devices, ranging from extracorporeal to implantable systems, aim to provide temporary or permanent respiratory support, potentially reducing the reliance on human donors. This chapter also discusses the role of gene and cell therapies in enhancing the function and survival of transplanted lungs. Ex vivo lung perfusion platforms are highlighted for their utility in delivering these therapies, optimising graft condition before transplantation. The integration of these bioengineering innovations could significantly impact the future of LTx, offering new lifelines to patients in need.</p>}}, author = {{Lindstedt, Sandra and Perch, Michael and Meloni, Federica and Niroomand, Anna}}, booktitle = {{Lung Transplantation}}, editor = {{Perch, M and Meloni, F and Vos, R}}, issn = {{2312-508X}}, language = {{eng}}, pages = {{277--285}}, publisher = {{European Respiratory Society}}, series = {{ERS Monograph}}, title = {{New frontiers in lung transplantation : a bioengineering perspective}}, url = {{http://dx.doi.org/10.1183/2312508X.10004924}}, doi = {{10.1183/2312508X.10004924}}, volume = {{2024}}, year = {{2024}}, }